United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - carefully consider the potential benefits and risks of naproxen tablets and other treatment options before deciding to use naproxen tablets. use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals ( see warnings: gastrointestinal bleeding, ulceration, and perforation ). naproxen tablets are indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile arthritis naproxen tablets are also indicated: - for relief of the signs and symptoms of tendonitis - for relief of the signs and symptoms of bursitis - for relief of the signs and symptoms of acute gout - for the management of pain - for the management of primary dysmenorrhea naproxen tablets are contraindicated in the following patents: - known hypersensitivity (e.g., anaphylactic reactions and serious skin rea

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - carefully consider the potential benefits and risks of naproxen tablets and other treatment options before deciding to use naproxen tablets. use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals ( see warnings: gastrointestinal bleeding, ulceration, and perforation ). naproxen tablets are indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile arthritis naproxen tablets are also indicated: - for relief of the signs and symptoms of tendonitis - for relief of the signs and symptoms of bursitis - for relief of the signs and symptoms of acute gout - for the management of pain - for the management of primary dysmenorrhea naproxen tablets are contraindicated in the following patents: - known hypersensitivity (e.g., anaphylactic reactions and serious skin rea

Australia - English - Department of Health (Therapeutic Goods Administration)

mega lifesciences (australia) pty ltd - ubidecarenone, quantity: 300 mg - capsule, soft - excipient ingredients: lecithin; white beeswax; glycerol; gelatin; soya oil; purified water; titanium dioxide; iron oxide black; brilliant blue fcf; brilliant scarlet 4r - helps enhance/promote healthy blood circulation ; maintain/support heart health

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

bio-life marketing sdn bhd - coenzyme q10 (ubidecarenone) -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mega lifesciences sdn. bhd. - coenzyme q10 (ubidecarenone); d-alpha tocopherol; zinc amino acid chelate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

bio-life marketing sdn bhd - coenzyme q10 (ubidecarenone) -

United States - English - NLM (National Library of Medicine)

saenggi life - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - hand sanitizer virus, bacteria, bacteria removal and infection prevention effect from all spaces and objects in daily life. recommended for repeated use. - do not eat. - do not spray directly on the body.

Singapore - English - HSA (Health Sciences Authority)

life technologies holdings pte ltd - microbiology - applied biosystems™ taqpath™ covid‑19 ht kit is the high‑throughput format of the taqpath™ covid‑19 ce‑ivd rt‑pcr kit. the kit is intended for use with the magmax™ viral/pathogen ii nucleic acid isolation kit, high‑throughput and is compatible with the amplitude™ platform. the kit contains the reagents and controls for a real‑time reverse transcription polymerase chain reaction (rt‑pcr) test intended for the qualitative detection of nucleic acid from sars‑cov‑2 in upper respiratory specimens (nasopharyngeal and nasal) from individuals suspected of covid-19.

Malta - English - Medicines Authority

pharmacare srl via marghera, 29 20149, milan, italy - film-coated tablet - sitagliptin 50 mg metformin hydrochloride 850 mg - drugs used in diabetes

Malta - English - Medicines Authority

pharmacare srl via marghera, 29 20149, milan, italy - film-coated tablet - sitagliptin 50 mg metformin hydrochloride 1000 mg - drugs used in diabetes